Table 3.
Univariate and multivariate analysis of the correlation between prognostic value and disease-free survival (DFS) and overall survival (OS) in 263 patients with type I endometrial cancers.
| Disease-free survival | Overall survival | |||||
| Characteristic | HR | 95% CI | P | HR | 95% CI | P |
| Univariate analyses | ||||||
| Age | 1.704 | 0.838–3.465 | .141 | 1.537 | 0.714–3.306 | .272 |
| Menopause | 3.542 | 1.367–9.175 | .009 | 4.081 | 1.419–11.741 | .009 |
| FIGO stage | 2.768 | 1.394–5.496 | .004 | 2.346 | 1.129–4.876 | .022 |
| Differentiation | 3.118 | 1.563–6.219 | .001 | 2.962 | 1.414–6.207 | .004 |
| Myometrial invasion | 7.900 | 3.876–16.102 | 1.3E−8 | 7.367 | 3.465–15.662 | 2.1E−7 |
| Tumor size | 1.167 | 0.506–2.690 | .717 | 1.339 | 0.571–3.141 | 0.502 |
| LVSI | 11.14 | 5.611–22.113 | 5.6E−12 | 10.08 | 4.859–20.912 | 5.5E−10 |
| LNM | 12.96 | 6.482–25.923 | 4.3E−13 | 15.948 | 7.630–33.335 | 1.8E−13 |
| TWIST1 expression | 4.019 | 1.948–8.294 | 1.7E−4 | 3.743 | 1.740–8.056 | .001 |
| Multivariate analyses | ||||||
| Menopause | 1.957 | 0.705–5.429 | .197 | 2.114 | 0.687–6.504 | .192 |
| FIGO stage | 0.841 | 0.351–2.018 | .699 | 0.588 | 0.228–1.516 | .272 |
| Differentiation | 1.634 | 0.750–3.561 | .216 | 1.729 | 0.757–3.949 | 0.194 |
| Myometrial invasion | 2.485 | 1.016–6.076 | .046 | 2.010 | 0.740–5.456 | .171 |
| LVSI | 3.112 | 1.191–8.136 | .021 | 2.438 | 0.869–6.842 | .090 |
| LNM | 2.813 | 1.023–7.733 | .045 | 5.927 | 1.917–18.319 | .002 |
| TWIST1 expression | 2.361 | 1.081–5.159 | .031 | 2.024 | 0.864–4.744 | .105 |